Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of 257.26 billion. The enterprise value is 283.04 billion.
| Market Cap | 257.26B |
| Enterprise Value | 283.04B |
Important Dates
The next estimated earnings date is Tuesday, October 28, 2025.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | Mar 11, 2025 |
Share Statistics
| Current Share Class | 1.94B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -3.37% |
| Shares Change (QoQ) | -0.96% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.84B |
Valuation Ratios
The trailing PE ratio is 18.84 and the forward PE ratio is 15.11.
| PE Ratio | 18.84 |
| Forward PE | 15.11 |
| PS Ratio | 4.66 |
| PB Ratio | 6.12 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.31 |
| P/OCF Ratio | 12.38 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.98, with an EV/FCF ratio of 14.65.
| EV / Earnings | 20.73 |
| EV / Sales | 5.17 |
| EV / EBITDA | 11.98 |
| EV / EBIT | 14.88 |
| EV / FCF | 14.65 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.78.
| Current Ratio | 0.82 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 1.37 |
| Debt / FCF | 1.69 |
| Interest Coverage | 17.47 |
Financial Efficiency
Return on equity (ROE) is 32.49% and return on invested capital (ROIC) is 16.47%.
| Return on Equity (ROE) | 32.49% |
| Return on Assets (ROA) | 11.88% |
| Return on Invested Capital (ROIC) | 16.47% |
| Return on Capital Employed (ROCE) | 26.39% |
| Revenue Per Employee | 727,251 |
| Profits Per Employee | 179,935 |
| Employee Count | 75,883 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.17 |
Taxes
In the past 12 months, Novartis AG has paid 1.97 billion in taxes.
| Income Tax | 1.97B |
| Effective Tax Rate | 12.62% |
Stock Price Statistics
The stock price has increased by +15.86% in the last 52 weeks. The beta is 0.56, so Novartis AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | +15.86% |
| 50-Day Moving Average | 122.80 |
| 200-Day Moving Average | 112.82 |
| Relative Strength Index (RSI) | 54.43 |
| Average Volume (20 Days) | 37,872 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of 55.19 billion and earned 13.65 billion in profits. Earnings per share was 6.85.
| Revenue | 55.19B |
| Gross Profit | 42.10B |
| Operating Income | 19.18B |
| Pretax Income | 15.61B |
| Net Income | 13.65B |
| EBITDA | 23.55B |
| EBIT | 19.18B |
| Earnings Per Share (EPS) | 6.85 |
Balance Sheet
The company has 6.73 billion in cash and 32.64 billion in debt, giving a net cash position of -25.91 billion.
| Cash & Cash Equivalents | 6.73B |
| Total Debt | 32.64B |
| Net Cash | -25.91B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 42.05B |
| Book Value Per Share | 21.69 |
| Working Capital | -5.78B |
Cash Flow
In the last 12 months, operating cash flow was 20.79 billion and capital expenditures -1.46 billion, giving a free cash flow of 19.32 billion.
| Operating Cash Flow | 20.79B |
| Capital Expenditures | -1.46B |
| Free Cash Flow | 19.32B |
| FCF Per Share | n/a |
Margins
Gross margin is 76.28%, with operating and profit margins of 34.76% and 24.74%.
| Gross Margin | 76.28% |
| Operating Margin | 34.76% |
| Pretax Margin | 28.28% |
| Profit Margin | 24.74% |
| EBITDA Margin | 42.68% |
| EBIT Margin | 34.76% |
| FCF Margin | 35.02% |
Dividends & Yields
This stock pays an annual dividend of 3.97, which amounts to a dividend yield of 3.00%.
| Dividend Per Share | 3.97 |
| Dividend Yield | 3.00% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 57.26% |
| Buyback Yield | 3.37% |
| Shareholder Yield | 6.37% |
| Earnings Yield | 5.31% |
| FCF Yield | 7.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Novartis AG has an Altman Z-Score of 3.73 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.73 |
| Piotroski F-Score | 6 |